{"id":5213,"date":"2010-04-15T11:34:20","date_gmt":"2010-04-15T16:34:20","guid":{"rendered":"http:\/\/blogs-devl.bu.edu\/bunow\/?p=5213"},"modified":"2011-01-20T14:42:05","modified_gmt":"2011-01-20T19:42:05","slug":"bu-research-breakthrough-on-diabetes","status":"publish","type":"post","link":"https:\/\/blogs-devl.bu.edu\/bunow\/2010\/04\/15\/bu-research-breakthrough-on-diabetes\/","title":{"rendered":"BU research breakthrough on diabetes"},"content":{"rendered":"<p><img loading=\"lazy\" class=\"alignleft size-thumbnail wp-image-5214\" src=\"http:\/\/blogs-devl.bu.edu\/bunow\/files\/2010\/04\/diabetes-150x150.jpg\" alt=\"diabetes\" width=\"150\" height=\"150\" \/>For the first time, tests of an artificial pancreas system developed by BU researchers have <a title=\"successfully maintained\" href=\"http:\/\/www.bu.edu\/phpbin\/news\/releases\/display.php?id=2066&amp;template=research-dev\" target=\"_blank\">successfully maintained <\/a>near-normal glucose levels in\u00a0patients without causing hypoglycemia.\u00a0 The tests, conducted at Massachusetts General Hospital, were the first of an artificial pancreas using both insulin and the blood-sugar-raising hormone glucagon.\u00a0 Department of Biomedical Engineering Prof. <a title=\"Edward Damiano\" href=\"http:\/\/www.bu.edu\/bme\/people\/primary\/damiano\/\" target=\"_blank\">Edward Damiano<\/a>, who co-led the research team, says such a system could replace the need for type-1 diabetics to constantly check their blood sugar and make treatment decisions every few hours.<\/p>\n<p><em>&#8220;It wouldn&#8217;t be a cure, but it has the potential to be the ultimate evolution of insulin therapy for type-1 diabetes.&#8221;<\/em><\/p>\n<p>Contact Sue McGreevy at MGH, 617-724-2764, <a href=\"mailto:smcgreevey@partners.org\">smcgreevey@partners.org<\/a>; or Kira Jastive at BU, 617-358-1240, <a href=\"mailto:kjastive@bu.edu\">kjastive@bu.edu<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>For the first time, tests of an artificial pancreas system developed by BU researchers have successfully maintained near-normal glucose levels in\u00a0patients without causing hypoglycemia.\u00a0 The tests, conducted at Massachusetts General Hospital, were the first of an artificial pancreas using both insulin and the blood-sugar-raising hormone glucagon.\u00a0 Department of Biomedical Engineering Prof. Edward Damiano, who co-led [&hellip;]<\/p>\n","protected":false},"author":114,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4491],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/posts\/5213"}],"collection":[{"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/users\/114"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/comments?post=5213"}],"version-history":[{"count":3,"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/posts\/5213\/revisions"}],"predecessor-version":[{"id":7785,"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/posts\/5213\/revisions\/7785"}],"wp:attachment":[{"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/media?parent=5213"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/categories?post=5213"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs-devl.bu.edu\/bunow\/wp-json\/wp\/v2\/tags?post=5213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}